-
1
-
-
0034075090
-
A patient with prolong prothrombin time due to an adverse interaction between fluorouracil and warfarin
-
Aki Z, Kotiloglu G, Ozyilkan O 2000 A patient with prolong prothrombin time due to an adverse interaction between fluorouracil and warfarin. Am J Gasroenterol 95: 1093-1094
-
(2000)
Am J Gasroenterol
, vol.95
, pp. 1093-1094
-
-
Aki, Z.1
Kotiloglu, G.2
Ozyilkan, O.3
-
2
-
-
0037812407
-
Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: The capecitabine experience
-
Blesch KS, Gieschke R, Tsukamoto Y, Reigner BG, Burger HU, Steimer JL 2003 Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience. Invest New Drug 21: 195-223
-
(2003)
Invest New Drug
, vol.21
, pp. 195-223
-
-
Blesch, K.S.1
Gieschke, R.2
Tsukamoto, Y.3
Reigner, B.G.4
Burger, H.U.5
Steimer, J.L.6
-
3
-
-
0017835513
-
Oral anticoagulant drugs: Pharmacokinetic aspects
-
Breckendridge AM 1978 Oral anticoagulant drugs: pharmacokinetic aspects. Semin Hematol 15: 19-26
-
(1978)
Semin Hematol
, vol.15
, pp. 19-26
-
-
Breckendridge, A.M.1
-
5
-
-
23044454675
-
Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer
-
Camidge R, Reigner B, Cassidy J, Garnge S, Abt M, Weidekamm E et al 2005 Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer. J Clin Oncol 21: 4719-4725
-
(2005)
J Clin Oncol
, vol.21
, pp. 4719-4725
-
-
Camidge, R.1
Reigner, B.2
Cassidy, J.3
Garnge, S.4
Abt, M.5
Weidekamm, E.6
-
6
-
-
0035522654
-
An adverse interaction between warfarin and capecitabine: A case report and review of the literature
-
Copur MS, Ledakis P, Bolton M, Morse AK, Werner T, Norvell M et al 2001 An adverse interaction between warfarin and capecitabine: a case report and review of the literature. Clin Colorectal Cancer 1: 182-184
-
(2001)
Clin Colorectal Cancer
, vol.1
, pp. 182-184
-
-
Copur, M.S.1
Ledakis, P.2
Bolton, M.3
Morse, A.K.4
Werner, T.5
Norvell, M.6
-
7
-
-
0035128503
-
Oral anticoagulants: Mechanism of action, clinical effectiveness and optimal therapeutic range
-
Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J et al 2001 Oral anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 119: 8-21
-
(2001)
Chest
, vol.119
, pp. 8-21
-
-
Hirsh, J.1
Dalen, J.E.2
Anderson, D.R.3
Poller, L.4
Bussey, H.5
Ansell, J.6
-
8
-
-
22244481595
-
Adverse interaction between capecitabine and warfarin in altered coagulation parameters and bleeding: Case report and review of the literature
-
Isaacs K, Haim N 2005 Adverse interaction between capecitabine and warfarin in altered coagulation parameters and bleeding: case report and review of the literature. J Chemother 17: 339-342
-
(2005)
J Chemother
, vol.17
, pp. 339-342
-
-
Isaacs, K.1
Haim, N.2
-
9
-
-
0037441969
-
Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: Can it be safely associated with fluorouracil-based chemotherapy?
-
Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B et al 2003 Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? J Clin Oncol 21: 736-739
-
(2003)
J Clin Oncol
, vol.21
, pp. 736-739
-
-
Masci, G.1
Magagnoli, M.2
Zucali, P.A.3
Castagna, L.4
Carnaghi, C.5
Sarina, B.6
-
10
-
-
0019799332
-
A method estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM, Sandor P, Roberts EA et al 1981 A method estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245
-
(1981)
Clin Pharmacol Ther
, vol.30
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
Sandor, P.4
Roberts, E.A.5
-
11
-
-
0036804638
-
Effect of fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats
-
Zhou Q, Chan E 2002 Effect of fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats. Eur J Pharma Sci 17: 73-80
-
(2002)
Eur J Pharma Sci
, vol.17
, pp. 73-80
-
-
Zhou, Q.1
Chan, E.2
|